Cubist Nears Goalpost Of Five Marketed Drugs In 2015
This article was originally published in The Pink Sheet Daily
Executive Summary
The antibiotic developer is gearing up to launch two new products now that it has filed an NDA for the antibiotic ceftolozane/tazobactam with FDA April 21.